Cargando…

Five-year quality of life assessment after carbon ion radiotherapy for prostate cancer

The aim of this study was to prospectively assess 5-year health-related quality of life (HRQOL) of patients treated with carbon ion radiotherapy (C-ion RT) for clinically localized prostate cancer. A total of 417 patients received carbon ion radiotherapy at a total dose of 63–66 Gray-equivalents (Gy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maruyama, Katsuya, Tsuji, Hiroshi, Nomiya, Takuma, Katoh, Hiroyuki, Ishikawa, Hitoshi, Kamada, Tadashi, Wakatsuki, Masaru, Akakura, Koichiro, Shimazaki, Jun, Aoyama, Hidefumi, Tsujii, Hirohiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439371/ https://www.ncbi.nlm.nih.gov/pubmed/28043947 http://dx.doi.org/10.1093/jrr/rrw122

Ejemplares similares

Up-to-date results of carbon-ion radiotherapy for prostate cancer
por: Nomiya, Takuma, et al.
Publicado: (2014)

Significant impact of biochemical recurrence on overall mortality in patients with high‐risk prostate cancer after carbon‐ion radiotherapy combined with androgen deprivation therapy
por: Kasuya, Goro, et al.
Publicado: (2016)

Cancer‐specific mortality of high‐risk prostate cancer after carbon‐ion radiotherapy plus long‐term androgen deprivation therapy
por: Kasuya, Goro, et al.
Publicado: (2017)

Phase I/II trial of definitive carbon ion radiotherapy for prostate cancer: evaluation of shortening of treatment period to 3 weeks
por: Nomiya, T, et al.
Publicado: (2014)

Carbon‐ion radiotherapy for urological cancers
por: Ishikawa, Hitoshi, et al.
Publicado: (2022)

A Review of Update Clinical Results of Carbon Ion Radiotherapy
por: Tsujii, Hirohiko, et al.
Publicado: (2012)

Updated long‐term outcomes after carbon‐ion radiotherapy for primary renal cell carcinoma
por: Kasuya, Goro, et al.
Publicado: (2018)

Prospective clinical trial of 12-fraction carbon-ion radiotherapy for primary renal cell carcinoma
por: Kasuya, Goro, et al.
Publicado: (2019)

Safety and Efficacy of Carbon-Ion Radiotherapy for Elderly Patients with High-Risk Prostate Cancer
por: Hiroshima, Yuichi, et al.
Publicado: (2022)

Identification of Early Biochemical Recurrence Predictors in High-Risk Prostate Cancer Patients Treated with Carbon-Ion Radiotherapy and Androgen Deprivation Therapy
por: Utsumi, Takanobu, et al.
Publicado: (2023)

Carbon-ion radiotherapy for locally advanced cervical cancer with bladder invasion
por: Shiba, Shintaro, et al.
Publicado: (2016)

Carbon Ion Radiotherapy for Oligo-Recurrence in the Lung
por: Yamamoto, Naoyoshi, et al.
Publicado: (2013)

Carbon ion radiotherapy in a hypofractionation regimen for stage I non-small-cell lung cancer
por: Takahashi, Wataru, et al.
Publicado: (2014)

Clinical Trial of Prophylactic Extended-Field Carbon-Ion Radiotherapy for Locally Advanced Uterine Cervical Cancer (Protocol 0508)
por: Wakatsuki, Masaru, et al.
Publicado: (2015)

Correction: Clinical Trial of Prophylactic Extended-Field Carbon-Ion Radiotherapy for Locally Advanced Uterine Cervical Cancer (Protocol 0508)
por: Wakatsuki, Masaru, et al.
Publicado: (2015)

The clinical relative biological effectiveness and prostate‐specific antigen kinetics of carbon‐ion radiotherapy in low‐risk prostate cancer
por: Kang, Yu‐Mei, et al.
Publicado: (2022)

Clinical trial of carbon ion radiotherapy for gynecological melanoma
por: Karasawa, Kumiko, et al.
Publicado: (2014)

Carbon ion radiotherapy for basal cell adenocarcinoma of the head and neck: preliminary report of six cases and review of the literature
por: Jingu, Keiichi, et al.
Publicado: (2010)

Progressive hypofractionated carbon‐ion radiotherapy for hepatocellular carcinoma: Combined analyses of 2 prospective trials
por: Kasuya, Goro, et al.
Publicado: (2017)

Carbon-ion radiotherapy for inoperable endometrial carcinoma
por: Irie, Daisuke, et al.
Publicado: (2018)

Dose constraints in the rectum and bladder following carbon-ion radiotherapy for uterus carcinoma: a retrospective pooled analysis
por: Okonogi, Noriyuki, et al.
Publicado: (2018)

Clinical impact of carbon‐ion radiotherapy on hepatocellular carcinoma with Child‐Pugh B cirrhosis
por: Hiroshima, Yuichi, et al.
Publicado: (2023)

Difference in distant failure site between locally advanced squamous cell carcinoma and adenocarcinoma of the uterine cervix after C-ion RT
por: Wakatsuki, Masaru, et al.
Publicado: (2015)

Carbon‐ion radiotherapy for oligometastatic liver disease: A national multicentric study by the Japan Carbon‐Ion Radiation Oncology Study Group (J‐CROS)
por: Shiba, Shintaro, et al.
Publicado: (2023)

Long-Term Outcomes of Carbon-Ion Radiotherapy for Malignant Gynecological Melanoma
por: Murata, Hiroto, et al.
Publicado: (2019)

Carbon-ion radiotherapy for marginal lymph node recurrences of cervical cancer after definitive radiotherapy: a case report
por: Tamaki, Tomoaki, et al.
Publicado: (2013)

Comparison of passive and scanning irradiation methods for carbon-ion radiotherapy for breast cancer
por: Matsubara, Hiroaki, et al.
Publicado: (2018)

Long-Term Results of High-Dose 2-Fraction Carbon Ion Radiation Therapy for Hepatocellular Carcinoma
por: Yasuda, Shigeo, et al.
Publicado: (2019)

Preliminary result of carbon-ion radiotherapy using the spot scanning method for prostate cancer
por: Takakusagi, Yosuke, et al.
Publicado: (2020)

Correction to: Preliminary result of carbon-ion radiotherapy using the spot scanning method for prostate cancer
por: Takakusagi, Yosuke, et al.
Publicado: (2022)

Clinical outcomes of carbon ion radiotherapy with concurrent chemotherapy for locally advanced uterine cervical adenocarcinoma in a phase 1/2 clinical trial (Protocol 1001)
por: Okonogi, Noriyuki, et al.
Publicado: (2018)

In vitro characterization of cells derived from chordoma cell line U-CH1 following treatment with X-rays, heavy ions and chemotherapeutic drugs
por: Kato, Takamitsu A, et al.
Publicado: (2011)

Dose prescription in carbon ion radiotherapy: How to compare two different RBE-weighted dose calculation systems
por: Molinelli, Silvia, et al.
Publicado: (2016)

Planning strategies for robust carbon-ion scanning radiotherapy for stage I esophageal cancer: a retrospective study
por: Suga, Makito, et al.
Publicado: (2023)

Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma
por: Iijima, Moito, et al.
Publicado: (2019)

The Emerging Role of Carbon-Ion Radiotherapy
por: Ebner, Daniel K., et al.
Publicado: (2016)

Secondary cancers after carbon‐ion radiotherapy and photon beam radiotherapy for uterine cervical cancer: A comparative study
por: Nitta, Yuki, et al.
Publicado: (2022)

Evaluation of Safety for Scanning Carbon-Ion Radiotherapy in Hemodialysis Patients With Prostate Cancer
por: Takakusagi, Yosuke, et al.
Publicado: (2022)

Prostate-specific antigen dynamics after neoadjuvant androgen-deprivation therapy and carbon ion radiotherapy for prostate cancer
por: Takakusagi, Yosuke, et al.
Publicado: (2020)

Single fraction carbon ion radiotherapy for colorectal cancer liver metastasis: A dose escalation study
por: Makishima, Hirokazu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_a13sqg62vhkvaon52i6842ksnv